SUPRACHOROIDAL INTERNAL DEVELOPMENT PIPELINE
STUDY DRUG
INDICATION
CURRENT STATUS
STUDY DRUG, INDICATION, CURRENT STATUS
PARTNER
LICENSED TERRITORY
CURRENT STATUS
PARTNER, INDICATION, CURRENT STATUS
Greater China, South Korea, ASEAN Countries, India, Australia, New Zealand

Greater China, South Korea, ASEAN Countries, India, Australia, New Zealand

DEVELOPMENT AND COMMERCIAL COLLABORATIONS USING SCS MICROINJECTOR®